Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models.

Marianecci C, Rinaldi F, Mastriota M, Pieretti S, Trapasso E, Paolino D, Carafa M.

J Control Release. 2012 Nov 28;164(1):17-25. doi: 10.1016/j.jconrel.2012.09.018. Epub 2012 Oct 2.

PMID:
23041542
2.

In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.

Paolino D, Muzzalupo R, Ricciardi A, Celia C, Picci N, Fresta M.

Biomed Microdevices. 2007 Aug;9(4):421-33.

PMID:
17252206
3.

Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models.

Marianecci C, Rinaldi F, Di Marzio L, Mastriota M, Pieretti S, Celia C, Paolino D, Iannone M, Fresta M, Carafa M.

Int J Nanomedicine. 2014 Jan 24;9:635-51. doi: 10.2147/IJN.S55066. eCollection 2014.

4.
5.

Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.

Junyaprasert VB, Singhsa P, Suksiriworapong J, Chantasart D.

Int J Pharm. 2012 Feb 28;423(2):303-11. doi: 10.1016/j.ijpharm.2011.11.032. Epub 2011 Dec 2.

PMID:
22155414
6.

Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.

Alsarra IA.

J Microencapsul. 2009 May;26(3):272-8. doi: 10.1080/02652040802305618. Epub 2008 Oct 20.

PMID:
18720197
7.

Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies.

Manconia M, Pendás J, Ledón N, Moreira T, Sinico C, Saso L, Fadda AM.

J Pharm Pharmacol. 2009 Apr;61(4):423-30. doi: 10.1211/jpp/61.04.0002.

PMID:
19298687
8.

Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.

Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, Kim DD, Kim JS, Yoo BK, Choi HG, Woo JS, Yong CS.

Int J Pharm. 2009 Jul 30;377(1-2):1-8. doi: 10.1016/j.ijpharm.2009.04.020. Epub 2009 Apr 24.

PMID:
19394413
9.

Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.

Verma P, Prajapati SK, Yadav R, Senyschyn D, Shea PR, Trevaskis NL.

Mol Pharm. 2016 Nov 7;13(11):3688-3699. Epub 2016 Sep 29.

PMID:
27632682
10.

Formulation strategies to modulate the topical delivery of anti-inflammatory compounds.

Puglia C, Rizza L, Offerta A, Gasparri F, Giannini V, Bonina F.

J Cosmet Sci. 2013 Sep-Oct;64(5):341-53.

PMID:
24139433
11.

Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.

Manosroi A, Jantrawut P, Manosroi J.

Int J Pharm. 2008 Aug 6;360(1-2):156-63. doi: 10.1016/j.ijpharm.2008.04.033. Epub 2008 Apr 26.

PMID:
18539416
12.

Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.

Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S.

Int J Pharm. 2006 Oct 12;323(1-2):1-10. Epub 2006 May 26.

PMID:
16837150
13.

Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.

Manosroi A, Khositsuntiwong N, Götz F, Werner RG, Manosroi J.

J Liposome Res. 2009;19(2):91-8. doi: 10.1080/08982100902731523.

PMID:
19241277
14.

Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.

Manca ML, Manconi M, Nacher A, Carbone C, Valenti D, Maccioni AM, Sinico C, Fadda AM.

Int J Pharm. 2014 Dec 30;477(1-2):176-86. doi: 10.1016/j.ijpharm.2014.10.031. Epub 2014 Oct 16.

PMID:
25455770
15.

Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate.

Wu Y, Yang W, Wang C, Hu J, Fu S.

Int J Pharm. 2005 May 13;295(1-2):235-45.

PMID:
15848008
16.

Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.

Alvi IA, Madan J, Kaushik D, Sardana S, Pandey RS, Ali A.

Anticancer Drugs. 2011 Sep;22(8):774-82. doi: 10.1097/CAD.0b013e328346c7d6.

PMID:
21799471
17.

A new approach for the evaluation of niosomes as effective transdermal drug delivery systems.

Muzzalupo R, Tavano L, Cassano R, Trombino S, Ferrarelli T, Picci N.

Eur J Pharm Biopharm. 2011 Sep;79(1):28-35. doi: 10.1016/j.ejpb.2011.01.020. Epub 2011 Feb 12.

PMID:
21303691
18.

Evaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesicles.

Puglia C, Trombetta D, Venuti V, Saija A, Bonina F.

J Pharm Pharmacol. 2004 Oct;56(10):1225-32.

PMID:
15482636
19.

Elastic liposomes for skin delivery of dipotassium glycyrrhizinate.

Trotta M, Peira E, Debernardi F, Gallarate M.

Int J Pharm. 2002 Jul 25;241(2):319-27.

PMID:
12100859
20.

Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery.

Gupta M, Vaidya B, Mishra N, Vyas SP.

Artif Cells Blood Substit Immobil Biotechnol. 2011 Dec;39(6):376-84. doi: 10.3109/10731199.2011.611476. Epub 2011 Sep 27.

PMID:
21951195

Supplemental Content

Support Center